Brigham and Women's Hospital and Mass. General have issued a plea to researchers who might have the instruments and components they would need to begin producing Covid-19 test kits:
As you know, there has been an ongoing challenge to clinically test patient samples for COVID-19 infection. In accordance with the recently released FDA guidance on Emergency Use Authorization for COVID-19 testing, clinical laboratories at Mass General Brigham are actively developing an assay to test patient samples.
To ensure these assays meet FDA requirements (under development), our clinical laboratories have to use specific kits, reagents, and equipment to perform urgent validation studies and subsequently test patient samples. Currently many of these items are either on back-order or do not exist for us to purchase.
The request says that once the things on the list become commercially available again, "we will replace them for you" and adds:
Thank you in advance for demonstrating firsthand how, when we come together as a system, we can fulfill critical needs to provide the best care to our patients and personnel.